Cannabidiol (CBD) Market Size By Product (Oils, Tinctures, Suppositories, Transdermal Patches, Isolates, Tablets, Capsules, Vape Oils, Creams & Roll-ons), By Application (Anxiety/Stress, Sleep/Insomnia, Chronic Pain, Migraine, Skin Care, Seizures, Joint Pain & Inflammation, Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacies, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020–2026

Published Date: Feb 2020  |  Report ID: GMI4541  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 180   |   Base Year: 2019

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Cannabidiol (CBD) Market size exceeded USD 2.8 billion in 2019 and is set to grow at around 52.7% CAGR between 2020 and 2026. Cannabidiol is a compound found in hemp plant which is being utilized due its therapeutic properties in humans. The growing trend among individuals to treat a variety of ailments such as anxiety, nausea, stress, chronic pain, neurological conditions and seizures are booming. This is due to the antibiotic and analgesic effects & properties present in cannabidiol.

Cannabidiol (CBD) Market

Get more details on this report - Request Free Sample PDF

CBD was first discovered in 1940 by Roger Adams in the U.S. In the late 1990s, cannabis re-surfaced and enabled the emphasis on specific cannabinoids making it more important. Post many studies and research, CBD became a trending topic as it has therapeutic properties to treat a wide array of ailments.

Increase in awareness regarding the potential benefits of CBD and increase in medical applications of cannabidiol will boost the adoption of CBD across the globe

The growing awareness and the acceptance of CBD products due to its potential health benefits will propel the CBD market growth positively. Post implementing the Agriculture Improvement Act of 2018, there has been an amplified demand for CBD-based products especially in countries such as the U.S., Canada, France, UK and Japan, among others. Few medical ailments treated with CBD include neurological conditions such as Parkinson’s disease, vomiting and nausea related to cancer chemotherapy, chronic pain conditions and other ailments.

As there are minimal studies available regarding the safety and efficacy of cannabidiol in humans and animals, major players in the market such as Tilray partnered with big pharmaceutical giants including Sandoz in 2018. Under this partnership, Sandoz will help in the sales of non-combustible and non-smokable medical cannabis products. This has created an ever-increasing demand for various forms of products such as CBD oils, capsules, isolates, creams and tinctures, thereby propelling the cannabidiol industry growth significantly.

Increasing adoption of tinctures for treating varied ailments will spur the market growth

Cannabidiol (CBD) Market

Get more details on this report - Request Free Sample PDF

Based on product, the CBD market size is segmented into oil, tinctures, suppository, transdermal patches, isolates, tablet, capsules, vape oil, creams & roll-on and others. Tinctures segment witnessed a substantial growth over the historical period that was valued at USD 0.39 million in 2015 and USD 389 million in 2019.

The gradual increase in product approvals after the implementation of Farm Bill (2018) coupled with the increase in CBD product manufacturers has fostered the growth of the market. For instance, founded in 2014, Elixinol company had an annual revenue of $2 million in 2015, and reached to $4 million in 2016. Similarly, Aurora Cannabis had a revenue of $ 18 million in 2017 and reported $55 million in sales for the year 2018. Therefore, the aforementioned factors will aid in boosting the growth of the cannabidiol industry.

Increase in sports injuries and growing geriatric population will propel the joint pain & inflammation segment market growth

Joint pain & inflammation application accounted for around 10% of the market share in 2019 and is expected to witness a similar trend during the market forecast period. Joint pain & inflammation affects around 15 million individuals every year in the U.S. and mostly prominent in the geriatric population. According to the U.S. Department of Health & Human Services, from 2013-2015 about 54.4 million individuals were affected by some form of arthritis, gout, rheumatoid arthritis or lupus.

Additionally, sports injuries are on a rise and consuming painkillers (opioids) will only supress the pain to some extent, whereas cannabidiol oil has been proven to be useful in various sports injuries. Few of the sports injuries includes Achilles tendonitis, minor sprain/strain and muscle spasm. Also, the increasing opioids addiction can be curbed utilizing cannabidiol-based products, as CBD has proven to have non-psychoactive compounds.

Rapid adoption of tinctures, oils, sprays, capsules as well as recently approved drugs will boost the market growth

Based on route of administration, the market is segmented into oral, topical, inhalation, transdermal patches, rectal and sublingual. Oral emerged as the largest segment in terms of route of administration and was valued at USD 1,508.1 million in 2019. This is due to the increased adoption of oral CBD products such as oils, sprays, tinctures, capsules and tablets.

Additionally, novel FDA approved drug launches such as Epidiolex (GW Pharmaceuticals) for treating Lennox-Gastaut syndrome and Dravet syndrome will further propel the cannabidiol market growth. Thus, all these factors will positively contribute to segmental growth in the upcoming years.

Potential applications of hemp derived CBD products is expected to drive the product adoption

Hemp market segment held the largest share in 2019 as hemp derived products does not consist of any psychoactive compounds as marijuana. Also, various countries such as U.S., Canada, China, Uruguay, France, Australia, Spain and Russia support the cultivation of hemp, that would further create profitable opportunities in the CBD industry.

The efficacy of cannabidiol is not yet concluded, thus continuous research and studies must be conducted for testing its effectiveness. Therefore, it is now legal to grow hemp for research purposes in around 47 countries, of which few countries are India, Chile, Ukraine, Hungary, Czech Republic, Portugal, Egypt, Romania, Russia and others. Hence, owing to the need for research studies, hemp segment is anticipated to witness a substantial growth.

Rapidly growing sales in online stores is boosting the adoption of CBD products

Cannabidiol Market By Distribution Channel

Get more details on this report - Request Free Sample PDF

Based on distribution channel, the market is segmented into online and offline. Offline is further segmented into hospital pharmacies and retail stores. Online segment witnessed a significant growth over the historical period, wherein, the revenue of 2016 was 2.3 million. Online segment offers various advantages over offline such as cheap prices, more variety, easy returns, convenience and privacy for discreet purchases. Thus, owing to these advantages, customers are largely attracted towards online selling platforms, thereby boosting the market growth in the upcoming years.

Presence of key players and rapidly growing adoption of CBD products in the U.S. will boost the cannabidiol market growth

North America cannabidiol industry is expected to grow with a higher growth rate throughout the market forecast period and is projected to exceed USD 54 billion by 2026. Presence of major players and the increase in adoption of cannabidiol products is driving the market growth. Key market leaders operating in the North American market include CBD American Shaman, Isodiol, Aurora Cannabis, CV Sciences, Tilray and Green Roads among others.

Also, with the changing regulatory scenarios and increase in awareness regarding the potential benefits of cannabidiol-based products, the market is expected to witness an exponential growth during the analysis period. Further, according to the Parkinson's Foundation, around one million individuals will be suffering from Parkinson’s disease in the U.S. by 2020, which will be a key factor for augmenting the industry growth.

In addition, Canada is expected to be the fastest growing country in the North American region as the sales of cannabidiol products have increased in the country owing to the legalization and sale of both cannabidiol and THC effective marijuana for medical purposes. This is expected to augment the cannabidiol market demand in Canada during the study period.

Execution of strategies such as partnerships and collaborations by major industry players will boost the market growth

Some of the prominent players operating in the CBD market share include Isodiol, Medical Marijuana Inc., CV Sciences, Aurora Cannabis, Canopy Growth Corporation, NuLeaf Naturals, Tilray, Green Roads, GW Pharmaceuticals, Folium Biosciences, Medterra, Charlotte's Web - CW Hemp, Endoca, Elixinol and Gaia Herbs, LLC. Development and launch of advanced products for better outcomes and rigorous marketing are few competitive strategies adopted by market players.

Recent industry developments:

  • In October 2019, Isodiol announced that it has entered into a strategic partnership with Vitamin Shoppe for the commercial release of Iso-Sport Products. This partnership was aimed at expanding its cannabidiol hemp extract product portfolio for meeting the increasing customer demand.
  • In November 2019, CV Sciences announced a new partnership with Southeastern Grocers to launch cannabidiol oil Plus brand that includes topical as well as dietary products. The aim for the partnership was to increase availability and distribution of company’s best-selling PlusCBD oil products.

The cannabidiol market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

By Product

  • Oils
  • Tinctures
  • Suppositories
  • Transdermal Patches
  • Isolates
  • Tablets
  • Capsules
  • Vape oils
  • Creams and Roll-on
  • Others

By Application

  • Anxiety/stress
  • Sleep/insomnia
  • Chronic Pain
  • Migraine
  • Skin Care
  • Seizures
  • Joint pain & inflammation
  • Neurological conditions
  • Others

By Route of Administration

  • Oral
  • Topical
  • Inhalation
  • Transdermal Patches
  • Rectal
  • Sublingual

By Source

  • Marijuana
  • Hemp

By Distribution Channel

  • Online
  • Offline
    • Hospital Pharmacies
    • Retail Stores

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Switzerland
    • United Kingdom
    • Netherlands
    • Italy
    • Others
  • Asia Pacific
    • Australia
    • New Zealand
    • Japan
    • Thailand
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Peru
    • Colombia
    • Others
  • Middle East & Africa
    • South Africa
    • Israel
    • Turkey
    • Others

Frequently Asked Questions (FAQ) :

The market size of cannabidiol surpassed USD 2.8 billion in 2019.
The industry share of cannabidiol is projected to expand at more than 52.7% CAGR during 2020-2026.
The CBD market size is slated to exceed USD 89 billion revenue by 2026, says a GMI report.
The North America cannabidiol industry is expected to exceed USD 54 billion by 2026.
Joint pain & inflammation accounted for around 10% of the market share in 2019 and is expected to witness a similar trend during the market forecast period.
Hemp is the largest source of cannabidiol as hemp derived products do not consist of any psychoactive compounds as marijuana.
Tinctures segment witnessed a substantial growth over the historical period that was valued at USD 389 million in 2019.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Premium Report Details

  • Published Date: Feb 2020
  • Pages: 180
  • Tables: 364
  • Charts / Figures: 14
  • Companies covered: 15
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market, request a free sample now

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X